XYL Reiterate Outperform and $168 PT - counter to the lingering concerns of some investors, remain confident in Xylem's normalized organic g

XYL Reiterate Outperform and $168 PT - counter to the lingering concerns of some investors, remain confident in Xylem's normalized organic growth and margin expansion trajectory @ OPCO